Literature DB >> 31341289

Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD.

Channabasavaiah B Gurumurthy1,2, Masahiro Sato3, Ayaka Nakamura4, Masafumi Inui5,6, Natsuko Kawano7, Md Atiqul Islam8,9, Sanae Ogiwara4, Shuji Takabayashi10, Makoto Matsuyama11, Shinichi Nakagawa12, Hiromi Miura8,13, Masato Ohtsuka14,15,16.   

Abstract

Methods to create genetically engineered mice involve three major steps: harvesting embryos from one set of females, microinjection of reagents into embryos ex vivo and their surgical transfer to another set of females. Although tedious, these methods have been used for more than three decades to create mouse models. We recently developed a method named GONAD (genome editing via oviductal nucleic acids delivery), which bypasses these steps. GONAD involves injection of CRISPR components (Cas9 mRNA and guide RNA (gRNA)) into the oviducts of pregnant females 1.5 d post conception, followed by in vivo electroporation to deliver the components into the zygotes in situ. Using GONAD, we demonstrated that target genes can be disrupted and analyzed at different stages of mouse embryonic development. Subsequently, we developed improved GONAD (i-GONAD) by delivering CRISPR ribonucleoproteins (RNPs; Cas9 protein or Cpf1 protein and gRNA) into day-0.7 pregnant mice, which made it suitable for routine generation of knockout and large-deletion mouse models. i-GONAD can also generate knock-in models containing up to 1-kb inserts when single-stranded DNA (ssDNA) repair templates are supplied. i-GONAD offers other advantages: it does not require vasectomized males and pseudo-pregnant females, the females used for i-GONAD are not sacrificed and can be used for other experiments, it can be easily adopted in laboratories lacking sophisticated microinjection equipment, and can be implemented by researchers skilled in small-animal surgery but lacking embryo-handling skills. Here, we provide a step-by-step protocol for establishing the i-GONAD method. The protocol takes ∼6 weeks to generate the founder mice.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31341289     DOI: 10.1038/s41596-019-0187-x

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  30 in total

Review 1.  BAR-Seq clonal tracking of gene-edited cells.

Authors:  Samuele Ferrari; Stefano Beretta; Aurelien Jacob; Davide Cittaro; Luisa Albano; Ivan Merelli; Luigi Naldini; Pietro Genovese
Journal:  Nat Protoc       Date:  2021-05-24       Impact factor: 13.491

2.  In Vivo Silencing/Overexpression of lncRNAs by CRISPR/Cas System.

Authors:  Marianna Vitiello; Laura Poliseno; Pier Paolo Pandolfi
Journal:  Methods Mol Biol       Date:  2021

Review 3.  From genotype to phenotype: genetics of mammalian long non-coding RNAs in vivo.

Authors:  Daniel Andergassen; John L Rinn
Journal:  Nat Rev Genet       Date:  2021-11-26       Impact factor: 53.242

4.  CRISPR-mediated Labeling of Cells in Chick Embryos Based on Selectively Expressed Genes.

Authors:  Masahito Yamagata; Joshua R Sanes
Journal:  Bio Protoc       Date:  2021-08-05

5.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

6.  Acrosin is essential for sperm penetration through the zona pellucida in hamsters.

Authors:  Michiko Hirose; Arata Honda; Helena Fulka; Miwa Tamura-Nakano; Shogo Matoba; Toshiko Tomishima; Keiji Mochida; Ayumi Hasegawa; Kiyoshi Nagashima; Kimiko Inoue; Masato Ohtsuka; Tadashi Baba; Ryuzo Yanagimachi; Atsuo Ogura
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-21       Impact factor: 11.205

7.  Actin at stereocilia tips is regulated by mechanotransduction and ADF/cofilin.

Authors:  Jamis McGrath; Chun-Yu Tung; Xiayi Liao; Inna A Belyantseva; Pallabi Roy; Oisorjo Chakraborty; Jinan Li; Nicolas F Berbari; Christian C Faaborg-Andersen; Melanie Barzik; Jonathan E Bird; Bo Zhao; Lata Balakrishnan; Thomas B Friedman; Benjamin J Perrin
Journal:  Curr Biol       Date:  2021-01-04       Impact factor: 10.834

8.  Progress of genome editing technology and developmental biology useful for radiation research.

Authors:  Kento Miura; Atsuo Ogura; Kohei Kobatake; Hiroaki Honda; Osamu Kaminuma
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 9.  Genetically modified mouse models to help fight COVID-19.

Authors:  Channabasavaiah B Gurumurthy; Rolen M Quadros; Guy P Richardson; Larisa Y Poluektova; Suzanne L Mansour; Masato Ohtsuka
Journal:  Nat Protoc       Date:  2020-10-26       Impact factor: 13.491

Review 10.  Recent Advances and Future Perspectives of In Vivo Targeted Delivery of Genome-Editing Reagents to Germ Cells, Embryos, and Fetuses in Mice.

Authors:  Masahiro Sato; Shuji Takabayashi; Eri Akasaka; Shingo Nakamura
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.